Parliamentary Search

Written question asked by Bob Blackman (Conservative) on Monday, 29 June 2026, in the House of Commons. It was due for an answer on Wednesday, 1 July 2026. It was answered by Preet Kaur Gill (Labour) on Monday, 6 July 2026 on behalf of the Department of Health and Social Care.

Neurology: Drugs

Question

To ask the Secretary of State for Health and Social Care, whether the Care Quality Commission's assessment framework requires providers to evidence medicines safety checks for psychiatric history, psychotropic medication use and previous psychiatric adverse drug reactions when prescribing neurological treatments with psychiatric warnings and contraindications.

Answer

The Care Quality Commission’s (CQC) Single assessment framework includes a quality statement that requires service providers to ensure medicines and treatments are safe and meet people’s needs and preferences by enabling them to be involved in planning, including when changes to treatment and medication happen.

People’s medicines should be appropriately prescribed, supplied, and administered in line with relevant legislation or national guidance, and in line with the Mental Capacity Act 2005. Accurate and up-to-date information about people’s medicines should also be available and there should be appropriate arrangements for the safe management, use, and oversight of controlled drugs.

The CQC expects all medicines to be prescribed appropriately and that the prescriber has the necessary information about the patient to do so safely, which includes previous responses to medicines such as adverse drug reactions. Patients should be fully informed of the risks with any treatment, including any potential side effects.

Secondary information

Type
Written question
Reference
13786
Session
2026-27
Subjects
Drugs Mental health Neurology Side effects
Link
View this Written question on www.parliament.uk